MARC record from Internet Archive

LEADER: 03450cam 2200649 a 4500
001 ocm26134185
003 OCoLC
005 20200819190821.0
008 921013s1992 nyua b 001 0 eng
010 $a 92226544
040 $aDLC$beng$cDLC$dWSM$dTMV$dNLM$dBAKER$dBTCTA$dYDXCP$dTULIB$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCA$dUKMGB
016 7 $a9311965$2DNLM
016 7 $a009786674$2Uk
019 $a28510319
020 $a8810630033$q(APH)
020 $a9788810630037$q(APH)
020 $a0471588369$q(Wiley-Liss)
020 $a9780471588368$q(Wiley-Liss)
020 $a1881063003
020 $a9781881063001
035 $a(OCoLC)26134185$z(OCoLC)28510319
050 00 $aRC684.A53$bO65 1992
060 00 $aQV 150$bO61a 1992
082 00 $a616.1/32061$220
100 1 $aOpie, Lionel H.
245 10 $aAngiotensin-converting enzyme inhibitors :$bscientific basis for clinical use /$cby Lionel H. Opie.
260 $aNew York :$bWiley-Liss :$bAuthor's Pub. House,$c1992.
300 $axi, 266 pages :$billustrations ;$c26 x 12 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aThe renin-angiotensin-aldosterone system and other proposed sites of action of angiotensin-converting enzyme inhibitors -- ACE inhibitors for hypertension -- ACE inhibitors and the kidney -- ACE inhibitors and the heart -- ACE inhibitors for congestive heart failure -- ACE inhibitors and the central nervous system -- ACE inhibitors: specific agents and pharmacokinetics -- ACE inhibitors: side-effects and contraindications -- ACE inhibitors: drug combinations and interactions -- ACE inhibitors, vascular structure, and arterial disease in hypertension -- ACE inhibitors, coronary artery disease, ischemic arrhythmias and postinfarct protection.
650 0 $aAngiotensin converting enzyme$xInhibitors$xTherapeutic use.
650 0 $aHypertension$xChemotherapy.
650 0 $aKidneys$xDiseases$xChemotherapy.
650 2 $aAngiotensin-Converting Enzyme Inhibitors$xpharmacology.
650 2 $aAngiotensin-Converting Enzyme Inhibitors$xtherapeutic use.
650 2 $aHeart Diseases$xdrug therapy.
650 2 $aHypertension$xdrug therapy.
650 7 $aAngiotensin converting enzyme$xInhibitors$xTherapeutic use.$2fast$0(OCoLC)fst00808854
650 7 $aHypertension$xChemotherapy.$2fast$0(OCoLC)fst00965835
650 7 $aKidneys$xDiseases$xChemotherapy.$2fast$0(OCoLC)fst00987391
776 08 $iOnline version:$aOpie, Lionel H.$tAngiotensin-converting enzyme inhibitors.$dNew York : Wiley-Liss : Author's Pub. House, 1992$w(OCoLC)645681392
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/enhancements/fy0607/92226544-t.html
856 42 $3Contributor biographical information$uhttp://catdir.loc.gov/catdir/enhancements/fy0607/92226544-b.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/enhancements/fy0607/92226544-d.html
938 $aBaker & Taylor$bBKTY$c37.95$d37.95$i0471588369$n0002161135$sactive
938 $aBaker and Taylor$bBTCP$n92226544
938 $aYBP Library Services$bYANK$n420926
029 1 $aAU@$b000009609877
029 1 $aNLM$b9311965
029 1 $aNZ1$b4492886
029 1 $aYDXCP$b420926
029 1 $aUKMGB$b009786674
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 76 OTHER HOLDINGS